Suchergebnisse - "Gyawali, Bishal"

PubPharm (6)

1

Optimal duration of adjuvant trastuzumab in treatment of early breast cancer : a meta-analysis of randomized controlled trials

enthalten in: Breast cancer research and treatment | 2019

von Niraula, S. | Gyawali, B.

2

Optimal duration of adjuvant trastuzumab in treatment of early breast cancer: a meta-analysis of randomized controlled trials

enthalten in: Breast cancer research and treatment | 2018

von Niraula, S. | Gyawali, B.

3

Optimal duration of adjuvant trastuzumab in treatment of early breast cancer: a meta-analysis of randomized controlled trials

enthalten in: Breast cancer research and treatment | 2018

von Niraula, S. | Gyawali, B.

4

Optimal duration of adjuvant trastuzumab in treatment of early breast cancer: a meta-analysis of randomized controlled trials

enthalten in: Breast cancer research and treatment | 2018

von Niraula, S. | Gyawali, B.

5

Duration of adjuvant trastuzumab in HER2 positive breast cancer : Overall and disease free survival results from meta-analyses of randomized controlled trials

enthalten in: Cancer treatment reviews | 2017

von Gyawali, B. | Niraula, S.

6

Duration of adjuvant trastuzumab in HER2 positive breast cancer: Overall and disease free survival results from meta-analyses of randomized controlled trials

enthalten in: Cancer treatment reviews

von Gyawali, B. | Niraula, S.

1
[1]